Journal of Molecular and Cellular Cardiology
Volume 49, Issue 5 , Pages 829-835 , November 2010

Paclitaxel accelerates spontaneous calcium oscillations in cardiomyocytes by interacting with NCS-1 and the InsP3R

  • Kun Zhang

      Affiliations

    • Department of Pharmacology, Yale University, New Haven, CT 06520, USA
    • Neuroscience Research Centre, Charité Universitätsmedizin Berlin, Berlin 10117, Germany
    • ,
  • Felix M. Heidrich

      Affiliations

    • Department of Pharmacology, Yale University, New Haven, CT 06520, USA
    • Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden 01307, Germany
    • ,
  • Brenda DeGray

      Affiliations

    • Department of Pharmacology, Yale University, New Haven, CT 06520, USA
    • ,
  • Wolfgang Boehmerle

      Affiliations

    • Department of Pharmacology, Yale University, New Haven, CT 06520, USA
    • Neuroscience Research Centre, Charité Universitätsmedizin Berlin, Berlin 10117, Germany
    • ,
  • Barbara E. Ehrlich

      Affiliations

    • Department of Pharmacology, Yale University, New Haven, CT 06520, USA
    • Corresponding Author InformationCorresponding author. Department of Pharmacology, Yale University, 333 Cedar Street, New Haven, CT 06520-8066, USA. Tel.: +1 203 737 1158; fax: +1 203 737 2027.

Received 24 April 2010 ,Revised 12 August 2010 ,Accepted 18 August 2010.

References 

  1. Walsh V, Goodman J. Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug taxol. Soc Sci Med (1982). Nov 1999;49(9):1215–1225
  2. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;277(5698):665–667
  3. Rowinsky EK. Paclitaxel pharmacology and other tumor types. Semin Oncol. Dec 1997;24(6 Suppl 19):S19-1-S-2
  4. Woods TC, Marks AR. Drug-eluting stents. Annu Rev Med. 2004;55:169–178
  5. Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC. Cardiac disturbances during the administration of taxol. J Clin Oncol. 1991;9(9):1704–1712
  6. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001;37(13):1590–1598
  7. Boehmerle W, Splittgerber U, Lazarus MB, McKenzie KM, Johnston DG, Austin DJ, et al. Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism. Proc Natl Acad Sci USA. 2006;103(48):18356–18361Epub 2006 Nov 17
  8. Boehmerle W, Zhang K, Sivula M, Heidrich FM, Lee Y, Jordt SE, et al. Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain mediated NCS-1 degradation in neuronal cells. Proc Natl Acad Sci USA Jun 26. 2007;104(26):11103–11108
  9. Wang MS, Davis AA, Culver DG, Wang Q, Powers JC, Glass JD. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain. 2004;127(Pt 3):671–679Epub 2004 Feb 4
  10. Clapham DE. Calcium signaling. Cell. Dec 14 2007;131(6):1047–1058
  11. Uhlen P, Burch PM, Zito CI, Estrada M, Ehrlich BE, Bennett AM. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling. Proc Natl Acad Sci USA. 2006;103(7):2160–2165Epub 006 Feb 3
  12. Uhlen P. Spectral analysis of calcium oscillations. Sci STKE. 2004;2004(258):pl15
  13. Heidrich FM, Zhang K, Estrada M, Huang Y, Giordano FJ, Ehrlich BE. Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes. Circ Res. May 23 2008;102(10):1230–1238
  14. Rengifo J, Gibson CJ, Winkler E, Collin T, Ehrlich BE. Regulation of the inositol 1,4,5-trisphosphate receptor type I by O-GlcNAc glycosylation. J Neurosci. Dec 12 2007;27(50):13813–13821
  15. Kowalski RJ, Giannakakou P, Hamel E. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)). J Biol Chem. 1997;272(4):2534–2541
  16. Rodi DJ, Janes RW, Sanganee HJ, Holton RA, Wallace BA, Makowski L. Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. J Mol Biol. 1999;285(1):197–203
  17. Wu X, Bers DM. Sarcoplasmic reticulum and nuclear envelope are one highly interconnected Ca2+ store throughout cardiac myocyte. Circ Res. Aug 4 2006;99(3):283–291
  18. Schlecker C, Boehmerle W, Jeromin A, DeGray B, Varshney A, Sharma Y, et al. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest. 2006;116(6):1668–1674Epub 2006 May 11
  19. Nakamura TY, Sturm E, Pountney DJ, Orenzoff B, Artman M, Coetzee WA. Developmental expression of NCS-1 (frequenin), a regulator of Kv4 K+ channels, in mouse heart. Pediatr Res. 2003;53(4):554–557Epub 2003 Feb 20
  20. Ahuja P, Perriard E, Pedrazzini T, Satoh S, Perriard JC, Ehler E. Re-expression of proteins involved in cytokinesis during cardiac hypertrophy. Exp Cell Res. Apr 1 2007;313(6):1270–1283
  21. Ter Keurs HE, Boyden PA. Calcium and arrhythmogenesis. Physiol Rev. Apr 2007;87(2):457–506
  22. Lakireddy V, Bub G, Baweja P, Syed A, Boutjdir M, El-Sherif N. The kinetics of spontaneous calcium oscillations and arrhythmogenesis in the in vivo heart during ischemia/reperfusion. Heart Rhythm. Jan 2006;3(1):58–66
  23. Parker KK, Taylor LK, Atkinson JB, Hansen DE, Wikswo JP. The effects of tubulin-binding agents on stretch-induced ventricular arrhythmias. Eur J Pharmacol. Apr 6 2001;417(1–2):131–140
  24. Poindexter BJ, Smith JR, Buja LM, Bick RJ. Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes. Cell Calcium. Dec 2001;30(6):373–382
  25. Bergstralh DT, Ting JP. Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat Rev. May 2006;32(3):166–179
  26. Xia HJ, Dai DZ, Dai Y. Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats. Life Sci. Oct 4 2006;79(19):1812–1819
  27. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev. Aug 2006;7(8):589–600
  28. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. Apr 24 1997;386(6627):855–858

PII: S0022-2828(10)00319-6

doi: 10.1016/j.yjmcc.2010.08.018

Journal of Molecular and Cellular Cardiology
Volume 49, Issue 5 , Pages 829-835 , November 2010

Article Tools

* Image Usage & Resolution